Skip to main content
Log in

C-Reactive Protein as a Prognostic Variable That Reflects Uncontrolled Up-Regulation of the IL-1-IL-6 Network System in Colorectal Carcinoma

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Up-regulation of the IL-1-IL-6 network stimulates systemic expression of C-reactive protein (CRP).This cytokine network system plays a pivotal role in inducing angiogenic growth factors in in-testinalmucosa. Serum CRP level and tissue concentrations of cytokines in colorectal cancerpatients were determined and an in vitro model was employed to determine the time course ofinduction of IL-6 in Caco-2 cells. Increased serum CRP was associated with recurrent diseaseand shorter survival time. Intense surgical stress and the presence of an acute phase reactantwere independently associated with overexpression of IL-6 in the tumor. Enhanced IL-6 pro-teinexpression in Caco-2 cells induced by the initial treatment with IL-1β or lipopolysaccha-ridecould be abrogated by additional presupplementation of IL-1ra. The presence of an acutephase reactant reflects uncontrolled up-regulation of the local IL-1-IL-6 network system in thetumor, which may enhance the survival and proliferation of remnant cancer cells after tumorresection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Du Clos TW: Function of C-reactive protein. Ann Med 32(4): 274–278, 2000

    Google Scholar 

  2. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS: A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170(4): 319–322, 1995

    Google Scholar 

  3. Nozoe T, Matsumata T, Kitamura M, Sugimachi K: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. AmJ Surg 178(4): 335–338, 1998

    Google Scholar 

  4. Fransen EJ, Maessen JG, Elenbaas TW, van Aarnhem EE, van Dieijen-Visser MP: Enhanced preoperative C-reactive protein plasma levels as a risk factor for postoperative infections after car-diac surgery. Ann Thorac Surg 67(1): 134–138, 1999

    Google Scholar 

  5. Haupt W, Hohenberger W, Mueller R, Klein P, Christou NV: Association between preoperative acute phase response and postoperative complications. Eur J Surg 163(1): 39–44, 1997

    Google Scholar 

  6. Parikh AA, Salzman AL, Fisher JE, Szabo C, Hasselgren PO: Interleukin-1β and interferon-γ° regulate interleukin-6 production in cultured human intestinal epithelial cells. Shock 8(4): 249–255, 1997

    Google Scholar 

  7. Riche F, Dosquet C, Panis Y, Valleur P, Laisne MJ, Briard C, Wautier JL: Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease. J Am Coll Surg 180(6): 718–724, 1995

    Google Scholar 

  8. Syk I, Hedges SR, Zederfeldt B, Risberg B: Enhanced cytokine response to surgical trauma in patients with colorectal cancer. Int J Surg Investig 1(3): 167–176, 1999

    Google Scholar 

  9. Oka M, Iizuka N, Yamamoto K, Gondo T, Abe T, Hazama S, Akitomi Y, Koishihara Y, Ohsugi Y, Ooba Y, Ishihara T, Suzuki T: The influence of interleukin-6 on the growth of human esophageal carcinoma cell lines. J Interferon Cytokine Res 16(6): 1001–1006, 1996

    Google Scholar 

  10. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H: Autocrine generation and re-quirement of BSF-2/IL-6 for human multiple myelomas. Nature 332(6159): 83–85, 1988

    Google Scholar 

  11. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T: Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250(2): 607–610, 1989

    Google Scholar 

  12. Ballou SP, Kushner I: Creactive protein and the acute phase re-sponse. Adv Intern Med 37(3): 313–316, 1992

    Google Scholar 

  13. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Miyazawa Y, Shihratori T, Hayashi H, Aoki T, Sugaya M, Gunji Y, Kobayashi S, Ochiai T: Prognostic value of preoperative serum immunosup-pressive acidic protein in patients with esophageal squamous cell carcinoma. Dis Esophagus 16(2): 102–106, 2003

    Google Scholar 

  14. Kinoshita T, Ito H, Miki C: Serum interleukin-6 level reflects tumor proliferative activity in colorectal cancer patients. Cancer 85(12): 2526–2531, 1999

    Google Scholar 

  15. Miki C, Tonouchi H, Wakuda R, Hatada T, Inoue Y, Minato E, Kobayashi M, Kusunoki M: Intratumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 94(5): 1584–1592, 2002

    Google Scholar 

  16. Lu ZY, Bataille R, Poubelle P, Rapp MJ, Harousseau JL, Klein B: An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma. Stem Cells 13(Suppl 2): 28–34, 1995

    Google Scholar 

  17. Ben-Eliyahu S: The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroim-munology. Brain Behav Immun 17(Suppl 1): S27–S36, 2003

    Google Scholar 

  18. Tang R, Wang JY, Chien CR, Chen JS, Lin SE, Fan HA: The association between perioperative blood transfusion and survival of patients with colorectal cancer. Cancer 72: 341–348, 1993

    Google Scholar 

  19. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J: Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90: 1131–1136, 2003

    Google Scholar 

  20. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial in-fusion in the treatment of nonresectable liver metastases from col-orectal cancer. J Natl Cancer Inst 88: 252–258, 1996

    Google Scholar 

  21. Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo M: Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene 20(2): 198–208, 2001

    Google Scholar 

  22. Frassanito MA, Cusmai A, Iodice G, Dammacco F: Au-tocrine interleukin-6 production and highly malignant multiple myeloma: Relation with resistance to drug-induced apoptosis. Blood 97(2): 483–489, 2001

    Google Scholar 

  23. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robert-son M, Kufe DW, Anderson KC: Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89(1): 227–234, 1997

    Google Scholar 

  24. Miyamoto Y, Hosotani R, Doi R, Wada M, Ida J, Tsuji S, Kawaguchi M, Nakajima S, Kobayashi H, Masui T, Imamura M: Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. Anticancer Res 21(4A): 2449–2456, 2001

    Google Scholar 

  25. Woods KV, Adler-Storthz K, Clayman GL, Francis GM, Grimm EA: Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: Possible influence of p53 but not human papillomavirus E6/E7. Cancer Res 58: 3142–3149, 1998

    Google Scholar 

  26. Lu ZY, Bataille R, Poubelle P, Rapp MJ, Harousseau JL, Klein B: An interleukin 1 receptor antagonist blocks the IL-1 induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma. Stem Cells 2: 28–34, 1995

    Google Scholar 

  27. Yin M, Gopal V, Banavali S, Gartside P, Preisler H: Effects of an IL-1 receptor antagonist on acute myeloid leukemia cells. Leukemia 6: 898–901, 1992

    Google Scholar 

  28. Vidal-Vanaclocha F, Amezaga C, Asumendi A, et al.: Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54: 2667–2672, 1994

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miki, C., Konishi, N., Ojima, E. et al. C-Reactive Protein as a Prognostic Variable That Reflects Uncontrolled Up-Regulation of the IL-1-IL-6 Network System in Colorectal Carcinoma. Dig Dis Sci 49, 970–976 (2004). https://doi.org/10.1023/B:DDAS.0000034556.48527.6e

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000034556.48527.6e

Navigation